Skip to main content

Table 1 Patient characteristics and biological agent treatment

From: Switching to an alternative biological agent in juvenile idiopathic arthritis (I)

Current treatment

Sex M/F

ANA (+)

HLA B27 (+)

RF (+)

Uveitis

Data of s-JIA

Previous treatments

ETA n=58

11/47

19 (33%)

13 (22%)

2 (3%)

11 (19%)

 

ADA n=1

ADA n=16

2/14

6 (38%)

3 (19%)

 

14 (88%)

1 (7%)

ETA n=8

IFX n=1

AK n=9

5/4

 

1 (11%)

  

9 (100%)

ETA n=2

TCZ n=11

3/8

 

1 (9%)

  

6 (55%)

ETA n=7

IFX n=2

AK n=6

ADA n=3

IFX n=2

1/1

 

2 (100%)

   

ETA n=2

Untreated* n=13

4/9

2 (15%)

2 (15%)

 

1 (8%)

1** (8%)

ETA n=12

AK,TCZ n=1

  1. * In 12 cases ETA was withdrawn due to inactive disease. **One child had episodes of macrophage activation syndrome, being with and without biological agent.
Back to article page